These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 19303048)

  • 1. Immunomodulatory consequences of ODN CpG-polycation complexes.
    Partidos CD; Hoebeke J; Wieckowski S; Chaloin O; Bianco A; Moreau E; Briand JP; Desgranges C; Muller S
    Methods; 2009 Dec; 49(4):328-33. PubMed ID: 19303048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
    Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD
    J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo immunostimulatory effects of CpG ODN in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1238-44. PubMed ID: 16908068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN.
    Raney SG; Wilson KD; Sekirov L; Chikh G; de Jong SD; Cullis PR; Tam YK
    J Drug Target; 2008 Aug; 16(7):564-77. PubMed ID: 18686126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
    Macfarlane DE; Manzel L
    J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.
    Mutwiri GK; Nichani AK; Babiuk S; Babiuk LA
    J Control Release; 2004 May; 97(1):1-17. PubMed ID: 15147800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake, intracellular distribution, and novel binding proteins of immunostimulatory CpG oligodeoxynucleotides in microglial cells.
    Zhang Z; Weinschenk T; Schluesener HJ
    J Neuroimmunol; 2005 Mar; 160(1-2):32-40. PubMed ID: 15710455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of natural killer-like YT-INDY cells by oligodeoxynucleotides and binding by homologous pattern recognition proteins.
    Kaur H; Jaso-Friedmann L; Leary JH; Praveen K; Brahmi Z; Evans DL
    Scand J Immunol; 2005 Oct; 62(4):361-70. PubMed ID: 16253123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides.
    Wang Y; Krieg AM
    Vaccine; 2004 Jun; 22(20):2641-50. PubMed ID: 15193390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets.
    Zhang L; Tian X; Zhou F
    Int Immunopharmacol; 2006 Oct; 6(10):1623-31. PubMed ID: 16919835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells.
    Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P
    Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine.
    Linghua Z; Xingshan T; Yong G; Fengzhen Z
    Vaccine; 2006 Mar; 24(11):1874-9. PubMed ID: 16289506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.